Irinotecan only product in parenteral dose form
|
Product containing precisely irinotecan hydrochloride trihydrate 20 milligram/1 milliliter conventional release solution for infusion and/or injection (clinical drug)
Irinotecan hydrochloride trihydrate 20 mg/mL solution for infusion and/or injection
Id1209058002
StatusDefined
Has manufactured dose formSolution for infusion and/or injection
Plays roleAntineoplastic therapeutic role
Has BoSSIrinotecan hydrochloride trihydrate
Has concentration strength denominator unitmL
Has concentration strength numerator unitmg
Has precise active ingredientIrinotecan hydrochloride trihydrate
|
Irinotecan hydrochloride trihydrate 20 mg/mL solution for infusion
Irinotecan hydrochloride trihydrate 20 mg/mL solution for injection